Max Healthcare announces Rs.1,000-cr foray into Pune with 450-bed super speciality hospital
The state-of-the-art facility is expected to be commissioned over the next three years
The state-of-the-art facility is expected to be commissioned over the next three years
At one year, the drug met its primary and all key secondary endpoints, delivering significantly better weight maintenance than placebo
The center will deliver Certified Pre-Owned instruments restored to factory-grade standards and backed by Agilent Standard Warranty
The combination also outperformed chemotherapy on another important secondary endpoint
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
This recognition demonstrate excellence in intellectual property (IP) value creation.
The receipt of this permission paves way for the marketing of Datopotamab Deruxtecan powder for concentrate for solution for infusion 100 mg (r-DNA origin) in India
Patients with BRCA mutations often face aggressive disease and poor prognosis
The company shall process the change of name application with BSE Ltd. in due course
Subscribe To Our Newsletter & Stay Updated